The total number of patients enrolled across both parts is anticipated to exceed 650.

When doing open-heart surgery, the surgeon needs a still heart and lungs to work. The patient still needs oxygen circulated through the bloodstream to survive. Thus, cardiovascular perfusionists (also ...

A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater access to heart transplants. Xvivo Perfusion, a leader in organ transplant ...

TransMedics (Nasdaq:TMDX) received FDA investigational device exemption (IDE) for its next-generation OCS ENHANCE Heart trial.

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...

The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon emission ...

Using an organ from a donor who underwent cardiac death, Stanford Medicine surgeons transplanted a heart while it was beating—the first time such a procedure has been achieved. Initially performed by ...

The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, ...

New Clinical Indications Statement Expands Recommendations for Cardiac PET and Myocardial Blood Flow Quantification Based on the clinical and scientific evidence now available, there are no clinical ...